Hey Patch - I'm currently keeping one eye on MDVN. I started a position last July when it dipped into the low-mid 70s' just before ER. It's my kind of biotech. It has both revenue & profit, with a nice pipeline as well.
PTX will bounce when it acquires a new product IMO.
Good to hear from both you and Kitty..........may 2015 be another excellent year for us all!!
Not currently in - PTX is and has always been a trading stock for me personally. And yes........ energy stocks, even those that just process oil (i.e. CLMT) are quite perplexing!
Freddy, energy is freezing us all, LINE not doing too well like Beta Centauri. PTX booming, hope you are in PTX.
Very true. Currently, all Drysdale has at his disposal to buy an additional product(s) is stock. SEC form has been filed for some time now.
Hey You Guys -
Had an unexpected mandatory trip back to Alpha Centauri and then bounced back and forth between Alpha Centauri and the very cold Beta Centauri (ugh!!)
I could only use my NASA issued intergalactical LCRC (Laser Communications Relay Communicator) – which unfortunately doesn’t speak yahooise!
Had some Romulan Ale to drink on the trip back (yummy)
Glad to be back where it’s warm – where the weather suits my clothes!! :-)
PS - I hope everyone caught my Patriots giving the Colts a shellacking. Loved it!!!
PPS – Breaking News – A 44lb beaver was rescued in Tempe, AZ. I wonder IF he’s related to our good buddy Beav?? LOL
They will raise the old 2015 guidance at earnings meeting in Feb, in my opinion. This will allow this company to be able to expand in healthy fashion with cash flow increasing.
And it only had Silenor new to the market it would probably be valued at a billion dollars based on potential. This is very cheap. Over 50 mil rev. in 4th quarter! looks like a lock for meeting 2015 targets which were very aggressive by many accounts.
you betcha!! Big increase, and I agree with the 2015 expected increases.
A good way to start the week!!
So now I guess you will buy PTX, the sales guidance for 2014 was just increased well over yahoo estimates and you can bet this bodes well for 2015 numbers. I told you I will rely on the excellent management skills of Drysdale, PTX will be Booming going into earnings and after.
The est #s for PTX were squirrely on Fri, but they are back where they were. .91 with 226M or rev is the est for this yr. If that moves up, or they guide up, I add more shrs.
In the world of biotech investing, HZNP is like watching paint dry, but it dries very steadily.
AKAO has something to release soon about discussing there trial design etc, going forward with FDA. The trials may take two years from what I read. I have found getting these things cheaper is better, but how early is hard to judge sometimes. The sector is hot for various reasons, like GAIN Act provisions. Maybe hold some long is good. SYN, I looked at a while back, seems like the news events over pumped it on the pipeline, so it just isn't doing much. The Ciff Diff strategy is interesting, not sure how it would be received by the medical community. Sometimes we need to get in things when they aren't moving. These pipeline stocks are kind of 3rd middie line. Right now folks are buying the quality that have products and things that are hot like antibiotics on this pullback. The non-marginables seem to get liquidated to extremes and lag behind a bit, but of course any one of them could have a news release to send them higher at anytime, most folks don't like to wait on a stock with no products. This is only an opinion, so you make the call. It may be Pats and Seahawks, hard to say, anyone can win in football at any time.
Do you feel AKAO is worth more than a trade? Will do some research here. SYN is interesting, SYN - 004, C. difficile infection.
Thanks and have a CEMPerior - long - weekend! Pats vs. Hawks in SB?
penny - BTW - the numbers are now gone on PTX and several other stocks, maybe they are updating, best to you on your HZNP investment.
I have AKAO as you might know. RDHL could move up, they are volatile and thinly traded as an ADR out of Israel. SYN, pipeline company, maybe worth a trade. PRTK, they have several arms to their business, not pure antibiotics play. I went with CEMP instead.
Yeah, well HZNP has a 1 year head start on PTX from when HZNP was shredded down to $2. I have made money on HZNP and ever since this merger the stock hasn't done much, look back over the year, it was even higher than it is now. You should also notice that the same investors are in PTX and HZNP on the convertible notes. So you are saying each stock will make nearly $1 in earnings in the same year, but PTX is way cheaper on forward P/E. I will stick more closely with Drysdale, this company can also bring in additional drugs to sell. BTW - I learned how to do this from SNTS, which sells DEPO's drug. DEPO brought in a new drug to sell, PTX can do this also, it is in the business plans.
Any thoughts on SYN, PRTK, AKAO and RDHL? My ROTH is enjoying CEMP. In 2015, thinking about adding more CEMP or other. Appreciate your views.
Not to argue value, which can be in the eyes of the beholder, but HZNP is clearly a 30 buck stock in the next 12 months, maybe much more. Here's some thots.
First, on the surface, if you look at the YHOO/IBES eps est for this yr, you will see that over the last 90 days, PTX's has dropped from 96 to 91 cents/sh.
In that same period, HZNP has increased from .89 to 1.06. Momo in earnings is the best indicator of stock performance.
You shd also note that HZNP is on a steady upward slope, PTX is clearly in recovery mode.
More important, HZNP is getting ready to file an NDA to use their drugs to treat a rare disease, it's all discussed on their MB, and in their corp prezos. Rare disease drugs are pretty valuable, and if they get approved (at least 18 months) and get into production (add another 6 months), their additional rev could be 200-300M, with a P/S on that rev of at least 5, so an additional $1B-1.5B in mkt cap in 2 yrs.
My point is that they aren't really "apples to apples". I own both, and have 100% confidence in HZNP, and only have that same confidence in PTX bcse of the low price, if PTX was still 10, my confidence level would be much lower.